News

MedPage Today on MSN2d
Nasal Powder for Acute Migraine Gets FDA Nod
The FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, ...
Verywell Health3d
Dupixent: The First FDA-Approved Biologic Drug to Treat Uncontrolled COPD
Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...
Healio3d
FDA approves Zevaskyn for treatment of recessive dystrophic epidermolysis bullosa
The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a ...